Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study

  1. Lawthom, C.
  2. Bermejo, P.
  3. Campos, D.
  4. McMurray, R.
  5. Villanueva, V.
Revue:
Neurology and Therapy

ISSN: 2193-6536,  2193-8253

Année de publication: 2019

Volumen: 8

Número: 2

Pages: 491-504

Type: Article

DOI: 10.1007/S40120-019-0137-0 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus